Clik here to view.
‘436 died during clinical trials last year’
As many as 436 people died last year due to serious adverse events (SAE) during clinical trials and the Union Health Minister has said the deaths could be due to life-threatening diseases such as...
View ArticleClik here to view.
India’s drug control body’s hall of shame
14 years – that’s how long Deanxit, anti-depressant marketed by a Danish company was sold in this country until its safety and efficacy was questioned. The drug in question is an antidepressant which...
View ArticleClik here to view.
Can ethical committees stop illegal clinical trials?
In a move to discourage the rampant frequency with which untested drugs are released in India, all pharmaceutical companies that conduct clinical trials will have to register internal ethics...
View ArticleRanbaxy spurious drugs case: Jaslok hospital asks docs not to prescribe...
The ramifications of Ranbaxy’s admission of seven federal charges including selling adulterated drugs with intent to defraud and the subsequent fine of $500 million to resolve false claim allegations...
View ArticleRanbaxy spurious drugs case: Indian Medical Association asks DCGI to...
The Indian Medical Association (IMA) has asked the Drugs Controller General of India (DCGI) to investigate the quality of drugs sold by Ranbaxy Laboratories in India. ‘We will soon be writing to the...
View ArticleClik here to view.
Ranbaxy spurious drugs update: DCGI probe will take a month, Apollo suspends...
The DCGI will complete its preliminary examination into the charges that Ranbaxy pleaded guilty to in the US and whether those infringements have any ramifications in India, health secretary Keshav...
View ArticleRanbaxy gets assistance from the health ministry
New Delhi, June 7 (IANS): Backing pharma major Ranbaxy, who has been accused of marketing sub-standard medicines, the health ministry said there was nothing wrong with the quality of its drugs. ‘There...
View ArticleIs this the end of the Ranbaxy fairytale? Japanese owners thinking of...
Indian drug giants Ranbaxy Laboratories is facing an existential conundrum with Japanese owners Daiichi Sankyo, thinking of rechristening the company, perhaps in the hope that a name change will give...
View ArticleClik here to view.
‘Drug regulator CDSCO needs to be regulated’
New Delhi, June 23 (IANS) India’s drug regulator, it would seem, needs to be itself regulated, to go by a public suit the Supreme Court will hear on Monday. The Central Drugs Standard Control...
View ArticleClik here to view.
DCGI gives approval to develop and manufacture biological tissues
Drug Controller General of India has given an approval to a health care service provider to develop and manufacture tissues used for the treatment of unmet medical needs. The approval has been given...
View Article
